BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ocular Therapeutix, Inc. 

204 Second Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-895-3235 Fax: 781-895-3236


SEARCH JOBS




Industry
Biotechnology






 Company News
Ocular Therapeutix (OCUL) Announces Plans To Proceed With An NDA Submission For OTX-DP For Treatment Of Post-Surgical Ocular Pain Indication; Reports First Quarter 2015 Financial Results 5/15/2015 12:00:24 PM
Ocular Therapeutix (OCUL) To Report First Quarter 2015 Financial Results 5/7/2015 12:38:24 PM
Ocular Therapeutix (OCUL) To Present Eight Posters Highlighting Its Sustained Release Hydrogel Platform Technology At The Association for Research in Vision & Ophthalmology Annual Meeting 5/1/2015 11:10:34 AM
Ocular Therapeutix (OCUL) Reports Topline Clinical Data For Its Second Phase 3 Clinical Trial Evaluating OTX-DP For The Treatment Of Post-Surgical Ocular Inflammation And Pain 4/7/2015 6:45:06 AM
Ocular Therapeutix (OCUL) Stock Caves After Eye Pain Drug Flunks Pivotal Trial 4/7/2015 6:39:26 AM
Ocular Therapeutix, Inc. (OCUL) Reports Fourth Quarter And Full Year 2014 Financial Results 3/10/2015 11:13:52 AM
Ocular Therapeutix, Inc. (OCUL) Reports Positive Topline Clinical Data For The First Of Two Phase 3 Clinical Trials Evaluating OTX-DP For The Treatment Of Post-Surgical Ocular Inflammation And Pain 3/10/2015 11:10:19 AM
Ocular Therapeutix, Inc. (OCUL) To Report Fourth Quarter And Full Year 2014 Financial Results 3/4/2015 11:10:02 AM
Ocular Therapeutix, Inc. (OCUL) To Participate In Two Upcoming Investor Conferences 2/19/2015 12:27:15 PM
Ocular Therapeutix, Inc. (OCUL) To Present At The 17th Annual BIO CEO & Investor Conference 2/5/2015 11:35:12 AM
12345